← Every lobbying firm
LMH Strategic Solutions
A registered lobbying firm, and the clients it files for. Everything here comes from the quarterly disclosures it is required to make under the Lobbying Disclosure Act. Filed as LMH STRATEGIC SOLUTIONS.
Clients
7
named in its filings
Filings
14
2026
Fees reported
$520K
across every filing
Who it represents
Largest first, by what the filings report being paid.
| Client | Fees |
|---|---|
| Alkermes, Inc.Alkermes Plc | $120K |
| Alnylam Pharmaceuticals, Inc.Alnylam Pharmaceuticals Inc | $100K |
| Incyte CorporationIncyte Corp | $100K |
| PTC Therapeutics, Inc.PTC Inc | $100K |
| Ionis Pharmaceuticals, Inc.Ionis Pharmaceuticals Inc | $60K |
| Natera, Inc.Natera Inc | $20K |
| Insmed IncorporatedInsmed Inc | $20K |
Every filing
Newest first, and within a year the largest.
| Client | Fee |
|---|---|
| Alkermes, Inc. | $60K |
| Alkermes, Inc. | $60K |
| Alnylam Pharmaceuticals, Inc. | $50K |
| Incyte Corporation | $50K |
| PTC Therapeutics, Inc. | $50K |
| PTC Therapeutics, Inc. | $50K |
| Alnylam Pharmaceuticals, Inc. | $50K |
| Incyte Corporation | $50K |
| Ionis Pharmaceuticals, Inc. | $30K |
| Ionis Pharmaceuticals, Inc. | $30K |
| Natera, Inc. | $20K |
| Insmed Incorporated | $20K |
| Natera, Inc. | — |
| Insmed Incorporated | — |
Source: quarterly LD-2 disclosures filed under the Lobbying Disclosure Act. A fee covers everything the firm did for that client in the period, so it cannot be attributed to any one issue on the list. A filing that states no figure contributes nothing rather than a zero. Clients with no ticker are kept: a trade association or a foreign ministry is as much a part of what the firm does as a listed company.